The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Molecular profiling of single circulating tumor cells with diagnostic intention
Open accessAbstract
Several hundred clinical trials currently explore the role of circulating tumor cell ( CTC ) analysis for therapy decisions, but assays are lacking for comprehensive molecular characterization of CTC s with diagnostic precision. We therefore combined a workflow for enrichment and isolation of pure CTCs with a non‐random whole genome amplification method for single cells and applied it to 510 single CTC s and 189 leukocytes of 66 CTC ‐positive breast cancer patients. We defined a genome integrity index ( GII ) to identify single cells suited for molecular characterization by different molecular assays, such as diagnostic profiling of point mutations, gene amplifications and whole genomes of single cells. The reliability of > 90% for successful molecular analysis of high‐quality clinical samples selected by the GII enabled assessing the molecular heterogeneity of single CTC s of metastatic breast cancer patients. We readily identified genomic disparity of potentially high relevance between primary tumors and CTC s. Microheterogeneity analysis among individual CTC s uncovered pre‐existing cells resistant to ERBB 2 ‐targeted therapies suggesting ongoing microevolution at late‐stage disease whose exploration may provide essential information for personalized treatment decisions and shed light into mechanisms of acquired drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
Wyllie, A. H. (1980) · Nature · doi:10.1038/284555a0 · Cited by 4,504
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. B., & Pantel, K. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3066 · Cited by 2,891
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · cited 1×
“Patient CTCs displayed heterogeneous morphology and staining intensity as in previous studies (Allard et al , 2004) adding observer variability to the CellSearch– DEPArray TM comparison.”
de Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,841
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Berns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Telenius, H., Carter, N. P., Bebb, C. E., Nordenskjo¨ld, M., Ponder, B. A. J., & Tunnacliffe, A. (1992) · Genomics · doi:10.1016/0888-7543(92)90147-k · Cited by 1,418
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Self-citationESR1 ligand-binding domain mutations in hormone-resistant breast cancer
Toy, W., Shen, Y., Won, H., Green, B., Sakr, R. A., Will, M., Li, Z., Gala, K., Fanning, S., King, T. A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2822 · Cited by 1,248
Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell
Zong, C., Lu, S., Chapman, A. R., & Xie, X. S. (2012) · Science · doi:10.1126/science.1229164 · Cited by 1,154 · cited 2×
“The method has several advantages over single cell amplification methods that employ random priming such as DOP (Telenius et al , 1992) or PEP (Zhang et al , 1992), MALBAC (Zong et al , 2012) or multiple strand displacement (Hou et al , 2012).”
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,135
Whole genome amplification from a single cell: implications for genetic analysis.
Zhang, L., Cui, X., Schmitt, K., Hubert, R., Navidi, W., & Arnheim, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5847 · Cited by 896
Bidard, F.-C., Peeters, D. J., Fehm, T., Nolé, F., Gisbert-Criado, R., Mavroudis, D., Grisanti, S., Generali, D., Garcia-Saenz, J. A., Stebbing, J., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70069-5 · Cited by 838
Self-citationGenetic clonal diversity predicts progression to esophageal adenocarcinoma
Maley, C. C., Galipeau, P. C., Finley, J. C., Wongsurawat, V. J., Li, X., Sanchez, C. A., Paulson, T. G., Blount, P. L., Risques, R.-A., Rabinovitch, P. S., et al. (2006) · Nature Genetics · doi:10.1038/ng1768 · Cited by 696
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
Danila, D. C., Heller, G., Gignac, G. A., Gonzalez-Espinoza, R., Anand, A., Tanaka, E., Lilja, H., Schwartz, L., Larson, S., Fleisher, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1506 · Cited by 665
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
Smerage, J. B., Barlow, W. E., Hortobagyi, G. N., Winer, E. P., Leyland-Jones, B., Srkalovic, G., Tejwani, S., Schott, A. F., O'Rourke, M. A., Lew, D. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2561 · Cited by 648
Schmidt-Kittler, O., Ragg, T., Daskalakis, A., Granzow, M., Ahr, A., Blankenstein, T. J. F., Kaufmann, M., Diebold, J., Arnholdt, H., Müller, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1331931100 · Cited by 631
Self-citationSingle-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm
Hou, Y., Song, L., Zhu, P., Zhang, B., Tao, Y., Xu, X., Li, F., Wu, K., Liang, J., Shao, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.028 · Cited by 541
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis
Yu, M., Ting, D. T., Stott, S. L., Wittner, B. S., Ozsolak, F., Paul, S., Ciciliano, J. C., Smas, M. E., Winokur, D., Gilman, A. J., et al. (2012) · Nature · doi:10.1038/nature11217 · Cited by 484
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
Klein, C. A., Blankenstein, T. J., Schmidt-Kittler, O., Petronio, M., Polzer, B., Stoecklein, N. H., & Riethmüller, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09838-0 · Cited by 479
Self-citationComparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
Klein, C. A., Schmidt-Kittler, O., Schardt, J. A., Pantel, K., Speicher, M. R., & Riethmüller, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4494 · Cited by 450
Self-citationJanku, F., Wheler, J. J., Westin, S. N., Moulder, S. L., Naing, A., Tsimberidou, A. M., Fu, S., Falchook, G. S., Hong, D. S., Garrido-Laguna, I., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.1196 · Cited by 447
Sieuwerts, A. M., Kraan, J., Bolt, J., van der Spoel, P., Elstrodt, F., Schutte, M., Martens, J. W. M., Gratama, J.-W., Sleijfer, S., & Foekens, J. A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn419 · Cited by 435
Fehm, T., Müller, V., Aktas, B., Janni, W., Schneeweiss, A., Stickeler, E., Lattrich, C., Löhberg, C. R., Solomayer, E., Rack, B., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1163-x · Cited by 353
Self-citationPark, S. Y., Gönen, M., Kim, H. J., Michor, F., & Polyak, K. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40724 · Cited by 324
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Liu, M. C., Shields, P. G., Warren, R. D., Cohen, P., Wilkinson, M., Ottaviano, Y. L., Rao, S. B., Eng-Wong, J., Seillier-Moiseiwitsch, F., Noone, A.-M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6664 · Cited by 319
A cmos chip for individual cell manipulation and detection
Manaresi, N., Romani, A., Medoro, G., Altomare, L., Leonardi, A., Tartagni, M., & Guerrieri, R. (2003) · IEEE Journal of Solid-State Circuits · doi:10.1109/jssc.2003.819171 · Cited by 314
Self-citationSelection and adaptation during metastatic cancer progression
Klein, C. A. (2013) · Nature · doi:10.1038/nature12628 · Cited by 273
Self-citationSchardt, J. A., Meyer, M., Hartmann, C. H., Schubert, F., Schmidt-Kittler, O., Fuhrmann, C., Polzer, B., Petronio, M., Eils, R., & Klein, C. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.003 · Cited by 259
Self-citationCirculating Breast Cancer Cells Are Frequently Apoptotic
Méhes, G., Witt, A., Kubista, E., & Ambros, P. F. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61667-7 · Cited by 237
Fischer, J. C., Niederacher, D., Topp, S. A., Honisch, E., Schumacher, S., Schmitz, N., Zacarias Föhrding, L., Vay, C., Hoffmann, I., Kasprowicz, N. S., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1313594110 · Cited by 227
Self-citationFrequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast Cancer
Chandarlapaty, S., Sakr, R. A., Giri, D., Patil, S., Heguy, A., Morrow, M., Modi, S., Norton, L., Rosen, N., Hudis, C., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1785 · Cited by 227
Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis
Stoecklein, N. H., & Klein, C. A. (2010) · International Journal of Cancer · doi:10.1002/ijc.24916 · Cited by 186
Self-citationGenetic and Phenotypic Diversity in Breast Tumor Metastases
Almendro, V., Kim, H. J., Cheng, Y.-K., Gönen, M., Itzkovitz, S., Argani, P., van Oudenaarden, A., Sukumar, S., Michor, F., & Polyak, K. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2357-t · Cited by 174
Perioperative Activation of Disseminated Tumor Cells in Bone Marrow of Patients With Prostate Cancer
Weckermann, D., Polzer, B. M., Ragg, T., Blana, A., Schlimok, G., Arnholdt, H., Bertz, S., Harzmann, R., & Klein, C. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.0563 · Cited by 157
Self-citationKraan, J., Sleijfer, S., Strijbos, M. H., Ignatiadis, M., Peeters, D. J. E., Pierga, J., Farace, F., Riethdorf, S., Fehm, T. N., Zorzino, L., et al. (2010) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20573 · Cited by 106
Self-citationGenomic Profiling of Isolated Circulating Tumor Cells from Metastatic Breast Cancer Patients
Magbanua, M. J. M., Sosa, E. V., Roy, R., Eisenbud, L. E., Scott, J. H., Olshen, A. B., Pinkel, D., Rugo, H. S., & Park, J. W. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3017 · Cited by 100
Magbanua, M. J. M., Sosa, E. V., Scott, J. H., Simko, J. P., Collins, C. C., Pinkel, D., Ryan, C. J., & Park, J. W. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-78 · Cited by 96
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
Cizkova, M., Dujaric, M. E., Lehmann‐Che, J., Scott, V., Tembo, O., Asselain, B. J. R., Pierga, J., Marty, M. E., de Crémoux, P., Spyratos, F., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.164 · Cited by 92
Quantitative Measurement of Melanoma Spread in Sentinel Lymph Nodes and Survival
Ulmer, A., Dietz, K., Hodak, I., Polzer, B., Scheitler, S., Yıldız, M., Czyż, Z. T., Lehnert, P., Fehm, T. N., Hafner, C. M., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001604 · Cited by 75
Self-citationRecent Advances in the Molecular Characterization of Circulating Tumor Cells
Lowes, L. E., & Allan, A. L. (2014) · Cancers · doi:10.3390/cancers6010595 · Cited by 62
Reliable Single Cell Array CGH for Clinical Samples
Czyż, Z. T., Hoffmann, M., Schlimok, G., Polzer, B., & Klein, C. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085907 · Cited by 53
Self-citation
Cited by
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Alix-Panabières, C., & Pantel, K. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1483 · Cited by 1,394
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0187-3 · Cited by 1,110
Tumour heterogeneity and metastasis at single-cell resolution
Lawson, D. A., Kessenbrock, K., Davis, R. T., Pervolarakis, N., & Werb, Z. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0236-7 · Cited by 606
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Metadata
- Authors
- Polzer, B., Medoro, G., Pasch, S., Fontana, F., Zorzino, L., Pestka, A., Andergassen, U., Meier‐Stiegen, F., Czyz, Z. T., Alberter, B., Treitschke, S., Schamberger, T., Sergio, M., Bregola, G., Doffini, A., Gianni, S., Calanca, A., Signorini, G., Bolognesi, C., Hartmann, A., Fasching, P. A., Sandri, M. T., Rack, B., Fehm, T., Giorgini, G., Manaresi, N., & Klein, C. A.
- Venue
- EMBO Molecular Medicine
- Published
- 2014-10-30
- Volume
- 6
- Issue
- 11
- Pages
- 1371-1386
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2096817916
- Cited by
- 254
- References
- 49
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.